<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <title>Competing interests</title>
 <p id="Par23">P.B. has received commercial support as a consultant from Axial Biotherapeutics, CuraSen, Fujifilm-Cellular Dynamics International, IOS Press Partners, LifeSci Capital, and Living Cell Technologies Ltd. He has received commercial support for grants/research from Lundbeck A/S and Roche. He has ownership interests in Acousort AB and Axial Biotherapeutics and is on the steering committee of the NILO-PD trial. J.H.K. has received commercial support as a consultant from Cellular Dynamics International, Inc., Michael J. Fox Foundation, Abbvie, Exicure, NSGENE, Guidepoint, Inhibikhase, Axovant, and Seelos B.A.K. and R.M. have no competing interests to disclose.</p>
</notes>
